Rice Hall James & Associates, LLC Uro Gen Pharma Ltd. Transaction History

Rice Hall James & Associates, LLC

$1.66 Billion
Q4 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 264,031 shares of URGN stock, worth $3.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

264,031

Previous 271,897 2.89%

Holding current value

$3.2 Million

Previous $3.45 Million 18.59%

% of portfolio

0.17%

Previous 0.2%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$10.52 - $13.11 $82,750 - $103,123	-7,866 Reduced 2.89%	264,031 $2.81 Million
Q3 2024 Oct 28, 2024	BUY	$12.7 - $17.92 $2.53 Million - $3.57 Million	199,110 Added 273.55%	271,897 $3.45 Million
Q2 2024 Aug 07, 2024	BUY	$12.72 - $19.2 $30,286 - $45,715	2,381 Added 3.38%	72,787 $1.22 Million
Q1 2024 Apr 23, 2024	BUY	$13.81 - $19.33 $7,098 - $9,935	514 Added 0.74%	70,406 $1.06 Million
Q4 2023 Feb 08, 2024	SELL	$10.87 - $15.93 $57,480 - $84,237	-5,288 Reduced 7.03%	69,892 $1.05 Million
Q3 2023 Nov 02, 2023	SELL	$8.84 - $22.64 $8,017 - $20,534	-907 Reduced 1.19%	75,180 $1.05 Million
Q2 2023 Jul 24, 2023	BUY	$8.75 - $14.29 $25,217 - $41,183	2,882 Added 3.94%	76,087 $787,000
Q1 2023 May 11, 2023	BUY	$7.99 - $11.02 $2,189 - $3,019	274 Added 0.38%	73,205 $676,000
Q4 2022 Jan 27, 2023	SELL	$7.55 - $11.96 $11,325 - $17,940	-1,500 Reduced 2.02%	72,931 $0
Q3 2022 Nov 01, 2022	SELL	$7.21 - $9.41 $259,747 - $339,004	-36,026 Reduced 32.62%	74,431 $619,000
Q2 2022 Aug 08, 2022	BUY	$5.12 - $8.74 $12,631 - $21,561	2,467 Added 2.28%	110,457 $905,000
Q1 2022 May 05, 2022	BUY	$5.92 - $9.73 $39,255 - $64,519	6,631 Added 6.54%	107,990 $941,000
Q4 2021 Feb 14, 2022	SELL	$9.03 - $19.13 $432,546 - $916,346	-47,901 Reduced 32.09%	101,359 $964,000
Q3 2021 Nov 09, 2021	SELL	$14.31 - $18.39 $1.32 Million - $1.7 Million	-92,377 Reduced 38.23%	149,260 $2.51 Million
Q2 2021 Jul 29, 2021	SELL	$15.2 - $20.94 $686,553 - $945,817	-45,168 Reduced 15.75%	241,637 $3.69 Million
Q1 2021 May 14, 2021	BUY	$17.99 - $26.96 $3.32 Million - $4.98 Million	184,752 Added 181.04%	286,805 $5.59 Million
Q4 2020 Feb 16, 2021	BUY	$17.54 - $25.43 $1.79 Million - $2.6 Million	102,053 New	102,053 $1.84 Million

Others Institutions Holding URGN

# of Institutions

137

Shares Held

36.2M

Call Options Held

57.7K

Put Options Held

9.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $276M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Uro Gen Pharma Ltd. Transaction History